Article

jdsupra.com on 2024-05-06 20:47

FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars

On April 25, 2024, the FDA published a notice of availability in the Federal Register for its revised draft guidance, entitled “Promotional Labeling ...

Related news

Pfizer Submits Citizen Petition to FDA Regarding Communications About Biosimilars jdsupra.com
United States
FDA Updates Draft Guidance on Promotional Labeling and Advertising Considerations for Biological Reference Products and Biosimilars jdsupra.com
Reg
Introduction to Biologics and Biosimilars jdsupra.com
FDA Acting Director Of Therapeutic Biologics And Biosimilars Provides Statement On Continued Efforts To Facilitate Competition In The Biologic Marketplace jdsupra.com
California , United States , Switzerland
[Webinar] Biologics and Biosimilars: Development with an Eye Towards FDA Approval - February 17th, 10:00am PST/1:00pm EST jdsupra.com
FDA Biosimilars Labeling Guidance jdsupra.com
FDA Releases Biosimilars Educational Materials jdsupra.com
FDA Releases Biosimilars Action Plan jdsupra.com
California , United States , Switzerland
FDA Continues to Approve Biosimilars jdsupra.com
California , United States , Switzerland
FDA Issues Draft Guidance on Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products jdsupra.com
California , United States , Switzerland
FDA Approves Sandoz Denosumab Biosimilars jdsupra.com
New Jersey
Biologics and Biosimilars Landscape: IP, Policy, and Market Developments jdsupra.com
Maryland , United States
Formycon and Biocon Biologics/Viatris Share Recent Biosimilars Development News jdsupra.com
Switzerland , United Kingdom , Australia , Canada
Q1 2022 Earnings Roundup: Biologics and Biosimilars Update jdsupra.com
Europe , Americas , North America , Shanghai , United States
Q1 2021 Earnings Roundup: Biologics and Biosimilars Update jdsupra.com
Switzerland , Australia , Canada , Brazil
Leadership Change at FDA’s Therapeutic Biologics & Biosimilars Staff jdsupra.com
California , United States , Switzerland
Advertising and Promotion Considerations for Biologics, Biosimilars, and Interchangeables jdsupra.com
FDLI Conference On Drug, Biologics, And Biosimilars Law And Regulation jdsupra.com
California , United States , Switzerland
Q3 2020 Earnings Roundup: Biologics and Biosimilars Update jdsupra.com
India , United States , Europe
Biosimilars Report On Biologics and Biosimilars Market in the United States Released This Week jdsupra.com
Europe , United States